SAGE - SAGE Therapeutics Inc. (SAGE) CEO Barry Greene on Q2 2021 Results - Earnings Call Transcript
SAGE Therapeutics, Inc. (SAGE) Q2 2021 Earnings Conference Call August 03, 2021, 08:00 ET Company Participants Jeff Boyle - Investor Contact Barry Greene - President, CEO & Director Stephen Kanes - Chief Medical Officer Kimi Iguchi - CFO & Treasurer Conference Call Participants Paul Matteis - Stifel, Nicolaus & Company Tazeen Ahmad - Bank of America Merrill Lynch Yasmeen Rahimi - Piper Sandler & Co. Laura Chico - Wedbush Securities Jay Olson - Oppenheimer Sumant Kulkarni - Canaccord Genuity Presentation Operator Good morning. Welcome to Sage Therapeutics Second Quarter 2021 Financial Results Conference Call. [Operator Instructions]. This call is being webcast live on the Investors and Media section of Sage's website at sagerx.com. This call is the property of Sage Therapeutics and recording, reproduction or transmission of this call without the expressed written consent of Sage Therapeutics is strictly prohibited. Please note that this call is being recorded. I would
For further details see:
SAGE Therapeutics, Inc. (SAGE) CEO Barry Greene on Q2 2021 Results - Earnings Call Transcript